228 related articles for article (PubMed ID: 31729407)
1. Microbial changes in relation to oral mucositis in autologous hematopoietic stem cell transplantation recipients.
Laheij AMGA; Raber-Durlacher JE; Koppelmans RGA; Huysmans MDNJM; Potting C; van Leeuwen SJM; Hazenberg MD; Brennan MT; von Bültzingslöwen I; Johansson JE; de Soet JJ; Haverman TM; Buijs MJ; Brandt BW; Rozema FR; Blijlevens NMA; Zaura E
Sci Rep; 2019 Nov; 9(1):16929. PubMed ID: 31729407
[TBL] [Abstract][Full Text] [Related]
2. Commensal oral microbiota impacts ulcerative oral mucositis clinical course in allogeneic stem cell transplant recipients.
Bruno JS; Heidrich V; Knebel FH; de Molla VC; Parahyba CJ; Miranda-Silva W; Asprino PF; Tucunduva L; Rocha V; Novis Y; Arrais-Rodrigues C; Camargo AA; Fregnani ER
Sci Rep; 2022 Oct; 12(1):17527. PubMed ID: 36266464
[TBL] [Abstract][Full Text] [Related]
3. Significant salivary changes in relation to oral mucositis following autologous hematopoietic stem cell transplantation.
van Leeuwen SJM; Proctor GB; Laheij AMGA; Potting CMJ; Smits O; Bronkhorst EM; Hazenberg MD; Haverman TM; Brennan MT; von Bültzingslöwen I; Raber-Durlacher JE; Huysmans MCDNJM; Rozema FR; Blijlevens NMA
Bone Marrow Transplant; 2021 Jun; 56(6):1381-1390. PubMed ID: 33420397
[TBL] [Abstract][Full Text] [Related]
4. Supersaturated Calcium Phosphate Rinse in Prevention and Treatment of Mucositis in Patients Undergoing Hematopoietic Stem Cell Transplant.
Bhatt N; Naithani R; Gupta SK
Exp Clin Transplant; 2017 Oct; 15(5):567-570. PubMed ID: 28229803
[TBL] [Abstract][Full Text] [Related]
5. Unusual oral mucosal microbiota after hematopoietic cell transplantation with glycopeptide antibiotics: potential association with pathophysiology of oral mucositis.
Muro M; Soga Y; Higuchi T; Kataoka K; Ekuni D; Maeda Y; Morita M
Folia Microbiol (Praha); 2018 Sep; 63(5):587-597. PubMed ID: 29532421
[TBL] [Abstract][Full Text] [Related]
6. The choice of multiple myeloma induction therapy affects the frequency and severity of oral mucositis after melphalan-based autologous stem cell transplantation.
Fleming S; Harrison SJ; Blombery P; Joyce T; Stokes K; Seymour JF; Prince HM; Ritchie D
Clin Lymphoma Myeloma Leuk; 2014 Aug; 14(4):291-6. PubMed ID: 24629850
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Analysis of Resilience of the Oral Microbiome in Allogeneic Stem Cell Transplant Recipients.
Laheij AMGA; Rozema FR; Brennan MT; von Bültzingslöwen I; van Leeuwen SJM; Potting C; Huysmans MDNJM; Hazenberg MD; Brandt BW; Zaura E; Buijs MJ; de Soet JJ; Blijlevens NNM; Raber-Durlacher JE
Microorganisms; 2022 Mar; 10(4):. PubMed ID: 35456787
[TBL] [Abstract][Full Text] [Related]
8. Icing oral mucositis: Oral cryotherapy in multiple myeloma patients undergoing autologous hematopoietic stem cell transplant.
Chen J; Seabrook J; Fulford A; Rajakumar I
J Oncol Pharm Pract; 2017 Mar; 23(2):116-120. PubMed ID: 26684614
[TBL] [Abstract][Full Text] [Related]
9. The salivary proteome in relation to oral mucositis in autologous hematopoietic stem cell transplantation recipients: a labelled and label-free proteomics approach.
van Leeuwen SJM; Proctor GB; Staes A; Laheij AMGA; Potting CMJ; Brennan MT; von Bültzingslöwen I; Rozema FR; Hazenberg MD; Blijlevens NMA; Raber-Durlacher JE; Huysmans MCDNJM
BMC Oral Health; 2023 Jul; 23(1):460. PubMed ID: 37420206
[TBL] [Abstract][Full Text] [Related]
10. Cryotherapy reduces oral mucositis and febrile episodes in myeloma patients treated with high-dose melphalan and autologous stem cell transplant: a prospective, randomized study.
Marchesi F; Tendas A; Giannarelli D; Viggiani C; Gumenyuk S; Renzi D; Franceschini L; Caffarella G; Rizzo M; Palombi F; Pisani F; Romano A; Spadea A; Papa E; Canfora M; Pignatelli A; Cantonetti M; Arcese W; Mengarelli A
Bone Marrow Transplant; 2017 Jan; 52(1):154-156. PubMed ID: 27526285
[No Abstract] [Full Text] [Related]
11. Oral candidiasis in hematopoietic cell transplantation patients: an outcome-based analysis.
Epstein JB; Hancock PJ; Nantel S
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Aug; 96(2):154-63. PubMed ID: 12931087
[TBL] [Abstract][Full Text] [Related]
12. Oral mucositis and outcomes of autologous hematopoietic stem-cell transplantation following high-dose melphalan conditioning for multiple myeloma.
Vera-Llonch M; Oster G; Ford CM; Lu J; Sonis S
J Support Oncol; 2007 May; 5(5):231-5. PubMed ID: 17564153
[TBL] [Abstract][Full Text] [Related]
13. Patterns of salivary microbiota injury and oral mucositis in recipients of allogeneic hematopoietic stem cell transplantation.
Shouval R; Eshel A; Dubovski B; Kuperman AA; Danylesko I; Fein JA; Fried S; Geva M; Kouniavski E; Neuman H; Armon-Omer A; Shahien R; Muller E; Noecker C; Borenstein E; Louzoun Y; Nagler A; Koren O
Blood Adv; 2020 Jul; 4(13):2912-2917. PubMed ID: 32598476
[TBL] [Abstract][Full Text] [Related]
14. Oral and Gut Microbiota Dysbiosis is Associated with Mucositis Severity in Autologous Hematopoietic Stem Cell Transplantation: Evidence from an Asian Population.
Wong SP; Er YX; Tan SM; Lee SC; Rajasuriar R; Lim YAL
Transplant Cell Ther; 2023 Oct; 29(10):633.e1-633.e13. PubMed ID: 37422196
[TBL] [Abstract][Full Text] [Related]
15. An analysis of oral microbial flora by T-RFLP in patients undergoing hematopoietic stem cell transplantation.
Takahashi M; Toyosaki M; Matsui K; Machida S; Kikkawa E; Ota Y; Kaneko A; Ogawa Y; Ando K; Onizuka M
Int J Hematol; 2020 Nov; 112(5):690-696. PubMed ID: 32770478
[TBL] [Abstract][Full Text] [Related]
16. Usefulness and safety of oral cryotherapy in the prevention of oral mucositis after conditioning regimens with high-dose melphalan for autologous stem cell transplantation for lymphoma and myeloma.
Batlle M; Morgades M; Vives S; Ferrà C; Oriol A; Sancho JM; Xicoy B; Moreno M; Magallón L; Ribera JM
Eur J Haematol; 2014 Dec; 93(6):487-91. PubMed ID: 24889275
[TBL] [Abstract][Full Text] [Related]
17. A Phase IIb, Multicenter, Open-Label, Safety, and Efficacy Study of High-Dose, Propylene Glycol-Free Melphalan Hydrochloride for Injection (EVOMELA) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation.
Hari P; Aljitawi OS; Arce-Lara C; Nath R; Callander N; Bhat G; Allen LF; Stockerl-Goldstein K
Biol Blood Marrow Transplant; 2015 Dec; 21(12):2100-2105. PubMed ID: 26327631
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy-induced oral mucositis is associated with detrimental bacterial dysbiosis.
Hong BY; Sobue T; Choquette L; Dupuy AK; Thompson A; Burleson JA; Salner AL; Schauer PK; Joshi P; Fox E; Shin DG; Weinstock GM; Strausbaugh LD; Dongari-Bagtzoglou A; Peterson DE; Diaz PI
Microbiome; 2019 Apr; 7(1):66. PubMed ID: 31018870
[TBL] [Abstract][Full Text] [Related]
19. Variability of high-dose melphalan exposure on oral mucositis in patients undergoing prophylactic low-level laser therapy.
Rodrigues GH; Jaguar GC; Alves FA; Guollo A; Camandoni VO; Damascena AS; Lima VCC
Lasers Med Sci; 2017 Jul; 32(5):1089-1095. PubMed ID: 28512727
[TBL] [Abstract][Full Text] [Related]
20. Salivary microbiome and oral mucositis in HSCT recipients: A pilot study.
Kwiatkowski D; Schuch LF; Curra M; Rampelotto PH; Montagner F; Daudt LE; Paz AA; Siebert M; Martins MD; Hashizume LN
Oral Dis; 2024 May; 30(4):2722-2727. PubMed ID: 37641195
[No Abstract] [Full Text] [Related]
[Next] [New Search]
